Status:
COMPLETED
Radiotherapy - Anastrazole Concomitant : Evaluation of the Side Effects
Lead Sponsor:
Centre Oscar Lambret
Conditions:
Breast Cancer
Eligibility:
FEMALE
Brief Summary
This study is a description of the radiation effects on the healthy tissues in patients receiving Anastrozole, sequential or in association with radiotherapy.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Post-menopausal woman without superior age limit
- No metastatic breast cancer, stade I-II, estrogen receptor positive or progesterone receptor positive, treated by conservative surgery or total mastectomy and requiring additive treatment by radiotherapy and hormonotherapy
- The patients including in another clinical trial can be include in this observatory
Exclusion
Key Trial Info
Start Date :
August 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2016
Estimated Enrollment :
490 Patients enrolled
Trial Details
Trial ID
NCT01183832
Start Date
August 1 2005
End Date
January 1 2016
Last Update
May 30 2019
Active Locations (29)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Henri Becquerel
Amiens, France
2
Clinique La Casamance
Aubagne, France
3
Hôpital Duchêne
Boulogne-sur-Mer, France
4
Centre François Baclesse
Caen, France